JLS Pharma
ActiveSummary
The computed 12-month bankruptcy probability of JLS Pharma is 1.8% (moderate). The 2025 annual accounts show equity of €29,426 and a net result of €71,664. Equity is shrinking by ~5% per year across the filed fiscal years. Its solvency ranks better than 23% of 10519 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
Axes · tick = 2024
Profitability100▲+27
Solvency38▼-32
Growth58▲+6
Track record94
Bankruptcy probability, 12 months
1.8%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €1,500 at 30 days acceptable
Liquidity tight (current ratio 1.28 against 2.32 in 2024; short-term debt: 74.7% and cash: 21.7% of total assets), and 87.3% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
12.7%
Return on assets
30.8%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 10519 sector peers (2025).
NBB · sector comparisonPosition among 10519 sector peers
Solvency
better than 23%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-07-2026, 22 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
22 d early
2024
67 d late
2023
20 d early
2022
25 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 4 accounts on average on the deadline day; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 11 July (3 of the last 4 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Turnover
€1.0m
EBIT margin
1.9%
Net result
€71,664▲ 913%
2024 · €7,075
Working capital
€48,713▼ 59.6%
2024 · €120,627
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line2022202320242025
Turnover€1.0m
Operating result€64,752-€19,195▼ 70.4%€9,513▼ 50.4%€95,618▲ 905%
Net result€50,834within the sector's middle half-€14,854within the sector's middle half▼ 70.8%€7,075within the sector's middle half▼ 52.4%€71,664within the sector's middle half▲ 913%
EBIT margin1.9%
Equity€75,834within the sector's middle half-€90,688within the sector's middle half▲ 19.6%€97,762within the sector's middle half▲ 7.8%€29,426below the sector's middle half▼ 69.9%
Total assets€234,512below the sector's middle half-€227,432below the sector's middle half▼ 3.0%€218,052below the sector's middle half▼ 4.1%€232,526below the sector's middle half▲ 6.6%
Debt€158,679-€136,744▼ 13.8%€120,290▼ 12.0%€203,100▲ 68.8%
Working capital€96,028within the sector's middle half-€112,217within the sector's middle half▲ 16.9%€120,627within the sector's middle half▲ 7.5%€48,713within the sector's middle half▼ 59.6%
Solvency32.3%within the sector's middle half-39.9%within the sector's middle half▲ 7.5pp44.8%within the sector's middle half▲ 5.0pp12.7%below the sector's middle half▼ 32.2pp
Current ratio1.74within the sector's middle half-2.04within the sector's middle half▲ 0.302.32within the sector's middle half▲ 0.281.28within the sector's middle half▼ 1.04
Return on assets (ROA)21.7%above the sector's middle half-6.5%within the sector's middle half▼ 15.1pp3.2%within the sector's middle half▼ 3.3pp30.8%above the sector's middle half▲ 27.6pp
Staff (FTE)2.8within the sector's middle half-2.6within the sector's middle half▼ 7.1%2.8within the sector's middle half▲ 7.7%2.6within the sector's middle half▼ 7.1%
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 905% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €232,526
Fixed assets
€10,159 ▲ 74.8%
Current assets
€222,367 ▲ 4.8%
Equity and liabilities €232,526
Equity
€29,426 ▼ 69.9%
Debt
€203,100 ▲ 68.8%
Debt's share of the balance-sheet total rises from 55.2% to 87.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€96,640▲
2024 · €10,848
Cash flow
€72,685▲
2024 · €8,410
Quick ratio
0.83▼
2024 · 1.56
Debt to equity
6.90▲
2024 · 1.23
ROE
243.5%▲
2024 · 7.2%
Interest coverage
99.66▲
2024 · 16.26
Debt ≤ 1 year
€173,654▲
2024 · €91,612
Debt > 1 year
€28,678=
2024 · €28,678
Income taxes
€23,784▲
2024 · €1,848
Staff costs
€198,138▲
2024 · €189,321
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,706 companies that looked in July 2024 the way this one looks now, 1.7% went bankrupt within 24 months and 96% are still going.
- Micro
- 5 to 10 years old
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
1.7%
went bankrupt
2.2%
stopped otherwise
96%
still going
A further 0.3% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 1.8% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,706 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Turnover70 | - | €1.0m | - | - | - |
| Goods, raw materials, services and sundry goods60/61 | - | €816,839 | - | - | - |
| Remuneration, social security and pensions62 | €238,627 | €186,530 | €189,321 | €198,138 | ▲ 4.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €2,814 | €1,335 | €1,335 | €1,021 | ▼ 23.5% |
| Other operating charges640/8 | €1,359 | €225 | €244 | €309 | ▲ 26.6% |
| Gross operating margin9900 | €307,552 | €207,284 | €200,413 | €295,086 | ▲ 47.2% |
| Operating profit (loss)9901 | €64,752 | €19,195 | €9,513 | €95,618 | ▲ 905% |
| Financial income75/76B | €39 | €21 | €78 | €799 | ▲ 929% |
| Recurring financial income75 | €39 | €21 | €78 | €799 | ▲ 929% |
| Financial charges65/66B | €1,203 | €537 | €667 | €970 | ▲ 45.3% |
| Recurring financial charges65 | €1,203 | €537 | €667 | €970 | ▲ 45.3% |
| Profit (loss) for the period before taxes9903 | €63,588 | €18,679 | €8,923 | €95,448 | ▲ 970% |
| Transfer to deferred taxes680 | €0 | - | - | - | - |
| Income taxes67/77 | €12,754 | €3,825 | €1,848 | €23,784 | ▲ 1,187% |
| Profit (loss) for the period9904 | €50,834 | €14,854 | €7,075 | €71,664 | ▲ 913% |
| Profit (loss) for the period to be appropriated9905 | €50,834 | €14,854 | €7,075 | €71,664 | ▲ 913% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €234,512 | €227,432 | €218,052 | €232,526 | ▲ 6.6% |
| Formation expenses20 | €0 | €0 | €0 | €0 | - |
| Fixed assets21/28 | €8,484 | €7,148 | €5,813 | €10,159 | ▲ 74.8% |
| Intangible fixed assets21 | €7,494 | €6,621 | €5,747 | €4,874 | ▼ 15.2% |
| Tangible fixed assets22/27 | €990 | €528 | €66 | €5,285 | ▲ 7,920% |
| Plant, machinery and equipment23 | - | - | - | €5,285 | - |
| Furniture and vehicles24 | €990 | €528 | €66 | €0 | ▼ 100% |
| Assets under construction and advance payments27 | €0 | €0 | €0 | €0 | - |
| Current assets29/58 | €226,029 | €220,283 | €212,239 | €222,367 | ▲ 4.8% |
| Stocks and contracts in progress3 | €65,550 | €65,312 | €69,510 | €78,137 | ▲ 12.4% |
| Stocks30/36 | €65,550 | €65,312 | €69,510 | €78,137 | ▲ 12.4% |
| Amounts receivable within one year40/41 | €58,091 | €54,160 | €53,972 | €93,069 | ▲ 72.4% |
| Trade receivables40 | €58,091 | €54,160 | €48,646 | €67,270 | ▲ 38.3% |
| Other amounts receivable41 | €0 | €0 | €5,326 | €25,799 | ▲ 384% |
| Cash at bank and in hand54/58 | €101,812 | €100,467 | €83,876 | €50,531 | ▼ 39.8% |
| Deferred charges and accrued income490/1 | €576 | €343 | €4,881 | €629 | ▼ 87.1% |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €234,512 | €227,432 | €218,052 | €232,526 | ▲ 6.6% |
| Equity10/15 | €75,834 | €90,688 | €97,762 | €29,426 | ▼ 69.9% |
| Contributions10/11 | €25,000 | €25,000 | €25,000 | €25,000 | = |
| Reserves13 | €50,834 | €65,688 | €72,762 | €4,426 | ▼ 93.9% |
| Distributable reserves133 | €50,834 | €65,688 | €72,762 | €4,426 | ▼ 93.9% |
| Amounts payable17/49 | €158,679 | €136,744 | €120,290 | €203,100 | ▲ 68.8% |
| Amounts payable after more than one year17 | €28,678 | €28,678 | €28,678 | €28,678 | = |
| Financial debts170/4 | €0 | - | - | - | - |
| Other amounts payable178/9 | €28,678 | €28,678 | €28,678 | €28,678 | = |
| Amounts payable within one year42/48 | €130,001 | €108,067 | €91,612 | €173,654 | ▲ 89.6% |
| Current portion of amounts payable after more than one year42 | €24,998 | €0 | - | - | - |
| Trade debts44 | €66,728 | €83,047 | €64,536 | €60,771 | ▼ 5.8% |
| Suppliers440/4 | €66,728 | €83,047 | €64,536 | €53,361 | ▼ 17.3% |
| Bills of exchange payable441 | - | - | - | €7,411 | - |
| Taxes, remuneration and social security45 | €38,275 | €25,020 | €27,076 | €42,882 | ▲ 58.4% |
| Taxes450/3 | €15,231 | €713 | €2,589 | €17,202 | ▲ 564% |
| Remuneration and social security454/9 | €23,044 | €24,307 | €24,487 | €25,681 | ▲ 4.9% |
| Other amounts payable47/48 | €0 | - | - | €70,000 | - |
| Accrued charges and deferred income492/3 | €0 | €0 | €0 | €769 | - |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €50,834 | €14,854 | €7,075 | €71,664 | ▲ 913% |
| + Depreciation and write-downs630 | €2,814 | €1,335 | €1,335 | €1,021 | ▼ 23.5% |
| Operating cash flow (approximation) | €53,648 | €16,189 | €8,410 | €72,685 | ▲ 764% |
| Investment in fixed assets (approximation) | - | €0 | €0 | -€5,368 | - |
| Change in cash | - | -€1,345 | -€16,591 | -€33,345 | ▼ 101% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
09-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Highest result since 2022net €71,664 ▲913%
Operating result €95,618, net result €71,664, both a record.
06-10
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 67 days late
2024
31-12
Financial
Weakest financial yearnet €7,075 ▼52.4%
Net result drops to €7,075, the lowest in the series; recovery starts the following year.
11-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
06-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, La Bruyère · 1 establishment unit since 2021
Ground area
1,013 m²
Building footprint
81 m²
Parcel 92088C0102/00K003, Wallonia. Linked by address, not a title deed.
1 establishment unit
JLS Pharma
since 20212.319.723.821
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92088C0102/00K003 | Wallonia | 1,013 m² | 1 · 81 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Carva Care
BE 0779.963.340
Heist-op-den-Berg · Eq €29,476
PROXY PHARMA
BE 0673.992.721
Beauvechain · Eq €29,362
PHARMACIE DE MANGOMBROUX
BE 0784.996.155
Verviers · Eq €29,518
SAB Pharma
BE 0687.692.485
Péruwelz · Eq €29,522
ACP-PHARMA
BE 1018.630.058
Affligem · Eq €29,290
Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 1,981 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded23-07-2021
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
47279Other retail sale of food
47750Retail sale of cosmetics and toilet articles
E-invoicing
Reachable via Peppol
Peppol ID
0208:0771655091
Registered
14-05-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.